Figure 4
From: Potential role of miR-9 and miR-223 in recurrent ovarian cancer
Independent TaqMan® PCR validation of top dysregulated miRNAs. Concordance was observed on TaqMan analysis for miR223 and miR9 between the training and expanded independent cohort of serous ovarian carcinomas (comprised of snap frozen tissues).
